Test Code: AUTO13 (You may customize this)
Method: Indirect Immunofluorescence Assay (IFA)
Sample Type: 🧫 CSF (preferred) or Blood (serum)
Reporting Time: ⏱ 7–14 days
Home Collection: ✅ Available
Detects autoantibodies against NMDA receptors (NR1 subunit) that can cause serious brain inflammation known as Autoimmune Encephalitis.
Sudden changes in behavior or personality
New-onset seizures or movement disorders
Memory loss, confusion, or hallucinations
Speech difficulty or mutism
Rapid decline in consciousness or responsiveness
Anti-NMDA Receptor Encephalitis
Autoimmune encephalitis in children and young adults
Secondary causes linked to ovarian teratomas in women
Early detection = better treatment response
Helps guide immunotherapy or tumor evaluation
Crucial in ruling out psychiatric misdiagnosis
CSF is more reliable than serum
Even if negative, clinical symptoms are very important
Always advised under neurologist's guidance
Instant home sample collection
Partnered with NABL/CAP labs
Easy tracking via app & website
Certified, trained, experienced phlebotomists
NMDA Receptor Antibody, IFA